[go: up one dir, main page]

EA200701052A1 - Новые производные замещённого арилпиперазина - Google Patents

Новые производные замещённого арилпиперазина

Info

Publication number
EA200701052A1
EA200701052A1 EA200701052A EA200701052A EA200701052A1 EA 200701052 A1 EA200701052 A1 EA 200701052A1 EA 200701052 A EA200701052 A EA 200701052A EA 200701052 A EA200701052 A EA 200701052A EA 200701052 A1 EA200701052 A1 EA 200701052A1
Authority
EA
Eurasian Patent Office
Prior art keywords
disorders
new derivatives
arylpiperazine
derivatives
substituted arylpiperazine
Prior art date
Application number
EA200701052A
Other languages
English (en)
Inventor
Мариа Люс Лопес Родригес
Беллинда Бенхаму Залама
Маргарита Вальхондо Фалькон
Original Assignee
Шварц Фарма, С.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шварц Фарма, С.Л. filed Critical Шварц Фарма, С.Л.
Publication of EA200701052A1 publication Critical patent/EA200701052A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описываются новые производные арилпиперазина с активностью как у лигандов подтипа 1А рецептора 5-гидрокситриптамин (5-HT), их стереоизомеры, способы их получения, их использование, а также фармацевтические композиции, содержащие эти производные, применяемые для лечения болезни Паркинсона, церебральных нарушений, вызванных тромбоэмолическим инсультом, черепно-мозговых травм, депрессий, мигрени. болей, психоза, патологических состояний тревоги, агрессивных нарушений или нарушений функции мочевыводящих путей.
EA200701052A 2004-12-27 2005-12-27 Новые производные замещённого арилпиперазина EA200701052A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106998A EP1674103A1 (en) 2004-12-27 2004-12-27 Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands
PCT/EP2005/057175 WO2006069993A1 (en) 2004-12-27 2005-12-27 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands

Publications (1)

Publication Number Publication Date
EA200701052A1 true EA200701052A1 (ru) 2008-02-28

Family

ID=34930175

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701052A EA200701052A1 (ru) 2004-12-27 2005-12-27 Новые производные замещённого арилпиперазина

Country Status (14)

Country Link
US (1) US20090036455A1 (ru)
EP (2) EP1674103A1 (ru)
JP (1) JP2008525384A (ru)
KR (1) KR20070097419A (ru)
CN (1) CN101087610A (ru)
AU (1) AU2005321228A1 (ru)
BR (1) BRPI0519269A2 (ru)
CA (1) CA2582663A1 (ru)
EA (1) EA200701052A1 (ru)
IL (1) IL181955A0 (ru)
MX (1) MX2007006842A (ru)
NO (1) NO20073732L (ru)
WO (1) WO2006069993A1 (ru)
ZA (1) ZA200702457B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2199086B1 (es) 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
MX2024007815A (es) 2022-01-11 2024-07-04 Suven Life Sciences Ltd Derivados heteroaliciclicos y su uso en el tratamiento de trastornos del snc.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3079295A (en) * 1994-09-01 1996-03-22 Universidad Complutense De Madrid New arylpiperazine derivatives

Also Published As

Publication number Publication date
US20090036455A1 (en) 2009-02-05
JP2008525384A (ja) 2008-07-17
ZA200702457B (en) 2008-04-30
KR20070097419A (ko) 2007-10-04
EP1674103A1 (en) 2006-06-28
EP1830854A1 (en) 2007-09-12
BRPI0519269A2 (pt) 2009-01-06
AU2005321228A1 (en) 2006-07-06
CA2582663A1 (en) 2006-07-06
WO2006069993A1 (en) 2006-07-06
CN101087610A (zh) 2007-12-12
NO20073732L (no) 2007-09-18
IL181955A0 (en) 2007-07-04
MX2007006842A (es) 2007-08-08

Similar Documents

Publication Publication Date Title
MA32898B1 (fr) Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
MX353625B (es) Combinaciones de agonistas del receptor de serotonina para el tratamiento de trastornos de movimiento.
EA200801551A1 (ru) Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
EA200600049A1 (ru) Способы получения 3 - бензазепинов
EA200800430A1 (ru) Замещённые тетрагидро-1н-пиридо[4,3,b] индолы как агонисты и антагонисты серотониновых рецепторов
EA201070535A1 (ru) Новые агонисты глюкокортикоидных рецепторов
MXPA05008212A (es) Nuevos compuestos de arilpiperazinilo.
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
MX2010004614A (es) Composiciones para tratamiento del mal de parkinson.
MA29088B1 (fr) Composes d'indazole-carboxamide.
MA31158B1 (fr) Composes tricycliques et leur utilisation comme modulateurs du recepteur de glucocorticoïdes
EA201000332A1 (ru) 1,3-двузамещенные 4-фенил-1н-пиридин-2-оны
EA200701588A1 (ru) Способы получения замещённых фенилпиразолмочевин
PT1716152E (pt) Compostos heterocíclicos fundidos e sua utilização como antagonistas do receptor metabotrópico para o tratamento de distúrbios gastrointestinais
EA200702253A1 (ru) Фармацевтическая композиция
EA200801302A1 (ru) Композиции и способы лечения нарушений цнс
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
MA34094B1 (fr) Dérivés de 3-(hétéroarylamino)-1,2,3,4-tétrahydro-9h-carbazole et leur utilisation comme modulateurs du récepteur de la prostaglandine d2
MA32506B1 (fr) Nouveaux composes
ATE552257T1 (de) Positive allosterische chinolizidinon-m1- rezeptormodulatoren
EA200701758A1 (ru) Замещённые арильные производные 1,4-пиразина
BRPI0809873A2 (pt) "composto, processo para a preparação do composto, método para o tratamento de uma desordem do sistema nervoso central, composição farmacêutica, uso do composto, método para testar antagonistas e antagonistas com seletividade para o receptor 5-th6 e método de tratamento"